Teva Pharmaceutical Industries

TEVA · TEL

$40.85−$0.46 (−1.11%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $41.31

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The company employs 31,173 full-time employees The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Employees: 31,173
Headquarters: TEL AVIV-YAFO
Listed: Jan 1, 1951
Sector: Health Care
Industry: Pharmaceuticals
Website: tevapharm.com

Leadership

Teva Pharmaceutical Industries executives
Name	Title	Since	Age
Sol Barer	—	—	76
Richard Francis	—	2023	55
Eliyahu Kalif	—	—	51
Richard Daniell	—	—	57
Christine Fox	—	—	56
Angus Grant	—	—	64
Eric Hughes	—	—	54
David McAvoy	—	—	61
Mark Sabag	—	—	53
Matthew Shields	—	—	50
Vikki Conway	—	—	52
Rosemary Crane	—	—	64
Amir Elstein	—	1995	68
Chen Lichtenstein	—	—	57
Gerald Lieberman	—	—	77
Roberto Mignone	—	—	52
Perry Nisen	—	—	68
Prof. Ronit Satchi - Fainaro	—	—	52
Prof. Varda Shalev	—	—	64
Janet Vergis	—	—	60
Tal Zvi Zaks	—	—	58
Ran Meir	—	2022	—

Revenue by product and region

Fiscal year ended Dec 31, 2024: $16.54B total revenue

By product

Product [Member]$14.43B87.2%
Distribution Service [Member]$1.58B9.5%
Product and Service, Other [Member]$365.00M2.2%
License [Member]$173.00M1.0%

Similar companies

Companies in the same industry as Teva Pharmaceutical Industries

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.